gastric subepithelial tumors
Showing 1 - 25 of >10,000
Submucosal Tumor of Gastrointestinal Tract Trial in Seoul (SurePath™)
Recruiting
- Submucosal Tumor of Gastrointestinal Tract
- SurePath™
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 23, 2022
Minimal Invasive Surgery for Gastric Subepithelial Tumor
Completed
- Gastric Subepithelial Tumor
- Endoscopic resection
- (no location specified)
Jul 7, 2022
Subepithelial Tumors of the Upper Gastrointestinal Tract Trial in Stockholm (Doppler investigation)
Recruiting
- Subepithelial Tumors of the Upper Gastrointestinal Tract
- Doppler investigation
-
Stockholm, SwedenKarolinska University Hospital & Karolinska Institute
Aug 1, 2023
Gastrointestinal Subepithelial Tumors Trial in Spain (Endoscopic band ligation without resection, SINK)
Terminated
- Gastrointestinal Subepithelial Tumors
- Endoscopic band ligation without resection
- SINK
-
Badalona, Barcelona, Catalonia, Spain
- +6 more
Sep 3, 2022
Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal
Recruiting
- Gastrointestinal Stromal Tumors
-
Fuzhou, Fujian, ChinaDepartment of Gastric Surgery, Fujian Medical University Union H
Jul 3, 2023
Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)
Recruiting
- Solid Tumor
- EGFR Amplification
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 28, 2023
Molecular Profiling in People With Gastric Tumors
Recruiting
- Stomach Neoplasms
- Stomach Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Advanced Pancreatic Carcinoma, Advanced Gastric Carcinoma Trial in Shenzhen (Claudin18.2 CAR-T cells)
Recruiting
- Advanced Pancreatic Carcinoma
- Advanced Gastric Carcinoma
- Claudin18.2 CAR-T cells
-
Shenzhen, Guangdong, ChinaLi Yu
Nov 17, 2022
Stage IV Gastric Cancer, Stage IIIA Gastric Cancer, Stage IIIB Gastric Cancer Trial (basic nutrition, oral supplement of
Not yet recruiting
- Stage IV Gastric Cancer
- +4 more
- basic nutrition
- oral supplement of creatine and curcumin
- (no location specified)
May 16, 2023
Surgery in Gastrointestinal Stromal Tumors for Treatment, Tumor
Recruiting
- Gastric Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 30, 2023
Submucosal Tumor of Stomach Trial in Hamburg (removal of submucosal gastric tumor preferably by Full Thickness Resection Device
Recruiting
- Submucosal Tumor of Stomach
- removal of submucosal gastric tumor preferably by Full Thickness Resection Device (FTRD)
-
Hamburg, GermanyUniversity Hospital Hamburg Eppendorf
Jun 20, 2021
HER2-positive Breast Cancer and Gastric Cancer Trial (68Ga labeled HER2 Affibody)
Not yet recruiting
- HER2-positive Breast Cancer and Gastric Cancer
- 68Ga labeled HER2 Affibody
- (no location specified)
Jun 5, 2022
HER2-overexpressed Advanced Solid Tumors After Progression of
Not yet recruiting
- HER2
- +3 more
- Disitamab Vedotin
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Dec 14, 2022
Cancer of Stomach, Oesophageal Cancer, Gastric Cancer Trial in Sydney
Recruiting
- Cancer of Stomach
- +8 more
-
Sydney, New South Wales, AustraliaWestmead Hospital
Mar 26, 2023
Metastatic Solid Tumor, NSCLC, Gastric Cancer Trial (RO7496353, Atezolizumab, Capecitabine)
Not yet recruiting
- Metastatic Solid Tumor
- +3 more
- RO7496353
- +7 more
- (no location specified)
May 22, 2023
EUS-Elastography and Contrast-Enhanced EUS Diagnostic Accuracy
Recruiting
- Gastrointestinal Subepithelial Tumors
- EUS-FNB
-
Rozzano, Milano, ItalyEndoscopy Unit, Humanitas Research Hospital
Mar 17, 2021
Esophageal Tumors, Gastric Tumors Malignant, Breast Cancer Trial in Stockholm ([68Ga]Ga-ABY-025 PET, Biopsy and analysis of HER2
Recruiting
- Esophageal Neoplasms
- +3 more
- [68Ga]Ga-ABY-025 PET
- Biopsy and analysis of HER2 expression
-
Stockholm, SwedenDepartment of Radiation Physics and Nuclear Medicine, Karolinska
Nov 25, 2022
Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)
Recruiting
- Gastric Cancer
- +6 more
- CEA CAR-T cells
-
Nanchang, Jiangxi, ChinaThe First Affiliated Hospital of Nanchang University
Aug 23, 2023
HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Metastatic Breast Cancer Trial in Germany, Spain,
Recruiting
- HER2-positive Breast Cancer
- +4 more
-
Essen, Germany
- +5 more
Nov 15, 2022
Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +8 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Jiangsu, ChinaXuzhou Second People's Hospital
May 8, 2023
Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)
Withdrawn
- Advanced Solid Tumor
- +9 more
- (no location specified)
Oct 16, 2023
Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Taiyuan (CEA-targeted CAR-T cells)
Recruiting
- Gastric Cancer
- +6 more
- CEA-targeted CAR-T cells
-
Taiyuan, Shanxi, China
- +1 more
Aug 24, 2023